Showing results (31-40 of 61) with videos related to
Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|October 28, 2011
The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: summary of the scientific assessment of the Committee for Medicinal Products for Human UseZahra Hanaizi, Barbara van Zwieten-Boot, Gonzalo Calvo, et al.Marine Environmental Research|September 10, 2020
Alexandrium pacificum and Alexandrium minutum: Harmful or environmentally friendly?Amandine M N Caruana, Mickaël Le Gac, Fabienne Hervé, et al.Marine Drugs|September 27, 2014
A feedback mechanism to control apoptosis occurs in the digestive gland of the oyster crassostrea gigas exposed to the paralytic shellfish toxins producer Alexandrium catenellaJean-Luc Rolland, Walid Medhioub, Agnes Vergnes, et al.Harmful Algae|November 11, 2023
Modelling spatiotemporal distributions of Vulcanodinium rugosum and pinnatoxin G in French Mediterranean lagoons: Application to human health risk characterisationAurélien Bouquet, Anne Thébault, Nathalie Arnich, et al.Harmful Algae|May 27, 2022
Prediction of Alexandrium and Dinophysis algal blooms and shellfish contamination in French Mediterranean Lagoons using decision trees and linear regression: a result of 10 years of sanitary monitoringAurélien Bouquet, Mohamed Laabir, Jean Luc Rolland, et al.The Oncologist|October 4, 2011
The European Medicines Agency review of Tegafur/Gimeracil/Oteracil (Teysuno™) for the treatment of advanced gastric cancer when given in combination with cisplatin: summary of the Scientific Assessment of the Committee for medicinal products for human use (CHMP)Petra Matt, Barbara van Zwieten-Boot, Gonzalo Calvo Rojas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2012
The European medicines agency review of eribulin for the treatment of patients with locally advanced or metastatic breast cancer: summary of the scientific assessment of the committee for medicinal products for human useElias Pean, Sigrid Klaar, Eva Gil Berglund, et al.Nature Reviews. Drug Discovery|July 2, 2011
Bridging the efficacy-effectiveness gap: a regulator's perspective on addressing variability of drug responseHans-Georg Eichler, Eric Abadie, Alasdair Breckenridge, et al.Clinical Toxicology (Philadelphia, Pa.)|February 8, 2022
Human poisonings by neurotoxic phycotoxins related to the consumption of shellfish: study of cases registered by the French Poison Control Centres from 2012 to 2019Sandra Sinno-Tellier, Eric Abadie, Luc de Haro, et al.Haematologica|June 30, 2011
The European Medicines Agency review of eltrombopag (Revolade) for the treatment of adult chronic immune (idiopathic) thrombocytopenic purpura: summary of the scientific assessment of the Committee for Medicinal Products for Human UseMaria Nieto, Gonzalo Calvo, Ian Hudson, et al.Pageof 7